Startup Funding Tracker
Home›People›Scott Huennekens
Scott Huennekens

Scott Huennekens

Chairman of the board at Elucid and INBRAIN Neuroelectronics

ExecutiveDirectorRoles at 3 startups
LinkedInLeadership page on elucid.com
Updated Nov 9, 2026·Latest SEC filing Oct 27, 2026·Suggest an edit

About Scott Huennekens

Scott Huennekens is chairman of the board of Elucid, a Boston company that makes AI software to read plaque in heart and neck arteries on CT scans. The company named him executive chairman in April 2023. In December 2025 he also became chairman of INBRAIN Neuroelectronics, which develops brain-computer interface therapies built on graphene. He also sits on the boards of Envista, QuidelOrtho, NeuroPace, Kardion and Q'Apel Medical.

Huennekens was president and CEO of Volcano Corporation from 2002 until Royal Philips bought it in February 2015. He then served as president, CEO and chairman of Verb Surgical, a surgical robotics company formed by Google and Johnson & Johnson, from August 2015 to December 2018. Earlier, he headed Digirad Corporation from 2000 to 2002 and worked at Baxter International from 1993 to 1997. His other board seats include Foldax (from January 2022), Uptake Medical (from 2011), EndoChoice (chairman from 2015) and Sonendo. He holds an MBA from Harvard Business School and a bachelor's degree in business administration from the University of Southern California.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Scott Huennekens in the role, so the role may have started earlier or lasted longer.

INBRAIN Neuroelectronics Current
Chairman of the Board
2025 – Present
Elucid Bioimaging Inc. Current
Executive Chairman of the Board
2023 – Present · Boston, MA
Elucid makes AI software that measures plaque in heart and neck arteries from CT scans to help doctors choose treatment.
Q'Apel Medical, Inc.
Director
2024 · Fremont, CA
Foldax, Inc.
Director
2022 – 2023 · Salt Lake City, UT
Verb Surgical
President, Chief Executive Officer and Chairman
2015 – 2018
EndoChoice
Chairman
From 2015
Volcano Corporation
President and Chief Executive Officer
2002 – 2015
Uptake Medical
Board member
From 2011
Digirad Corporation
President and Chief Executive Officer (2000 – 2002)
Chief Operating Officer (From 1997)
1997 – 2002
Baxter International
Division Vice President of Sales and Marketing
1993 – 1997
Envista
Board member
QuidelOrtho
Board member
NeuroPace
Board member
Kardion
Board member
Sonendo
Board member

Key Colleagues at Startups

The people Scott Huennekens works with at each company, as listed on that company's latest Form D.

Elucid Bioimaging Inc. · Form D/A, Oct 27, 2026
Blake Richards
Blake Richards
Chief Operating Officer
ML
Michael Lesh
Director
RK
EM
Evan Melrose
Director
SF
Kelly Huang
Kelly Huang
President and Chief Executive Officer, director
RP
Rajesh Panda
Director
Q'Apel Medical, Inc. · Form D, May 9, 2024
RN
R. Nelson
Chief Executive Officer and director
CM
LK
CM
Foldax, Inc. · Form D, Nov 7, 2023
KC
Ken Charhut
Director
JD
SR
GW
GC
Greg Casciaro
Executive officer and director
BH
Brant Heise
Director

Scott Huennekens in the News

Sources

  1. SECElucid Bioimaging Inc. Form D/A, filed Oct 27, 2026
  2. SECQ'Apel Medical, Inc. Form D, filed May 9, 2024
  3. SECFoldax, Inc. Form D, filed Nov 7, 2023
  4. PressElucid names Scott Huennekens executive chairman (April 25, 2023)
  5. PressINBRAIN Neuroelectronics appoints Scott Huennekens chairman (Business Wire release, December 10, 2025)
  6. Company siteBoard of directors page on qapelmedical.com
  7. PressQ'Apel Medical release on his joining its board (February 10, 2021)
  8. PressFoldax release on his joining its board (January 18, 2022)
  9. PressUptake Medical release on his joining its board (PR Newswire, March 1, 2011)
  10. SECEndoChoice Holdings S-1/A (2015), director biography